1-(4-(3-氨基-1H-吲唑-4-基)苯基)-3-(2-氟-5-甲基苯基)脲; 利尼伐尼
Linifanib(ABT-869; AL-39324; RG3635)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
5 mg 10 mg 25 mg
Product Availability
3-5days
Price
$66.00
Member price
Product Availability
3-5days
Price
$96.00
Member price
Product Availability
3-5days
Price
$166.00
Member price
Quantity
- +
Product Overview
Product Name Linifanib(ABT-869; AL-39324; RG3635)
CAS796967-16-3
FormulaC21H18FN5O
MW375.40
MDLMFCD11840918
AppearanceWhite to gray powder
Security information
Product details

Linifanib (formerly RG3635, ABT869, AL39324) is an orally bioavailable and ATP-competitive inhibitor of multiple kinases (e.g. VEGFR/PDGFR) with potential antitumor activity. Its IC50 values are 4 nM, 3 nM, 3 nM/4 nM, and 66 nM for KDR, CSF-1R, Flt-1/3, and PDGFRβ, respectively. Linifanib has strong antitumor efficaciousness in vivo and outstanding anti-proliferative activity in vitro.

Related literature
Related
Sorry, no related items
History
Vedolizumab
Linifanib(ABT-869; AL-39324; RG3635)
Evofosfamide (TH-302)
Bemcentinib | R428 | BGB324
Hyaluronic acid | Hyaluronan | Hyaluronate